Leysan Shaydullina
Directeur/Membre du Conseil chez HemaCore LLC
Profil
Leysan Shaydullina is currently the Vice Chairman at Panacela Labs, Inc., Director at HemaCore LLC, and Managing Director-Investment Management at Rusnano Management Co. LLC.
She previously worked as a Director at Selecta Biosciences, Inc., Associate at Rusnano OJSC, and Head-Investment Department at Idea Innovative Technopark CJSC.
Dr. Shaydullina holds an MBA from The Russian Presidential Academy of National Economy & Public and a doctorate from Kazan State Medical University.
Postes actifs de Leysan Shaydullina
| Sociétés | Poste | Début |
|---|---|---|
HemaCore LLC
 HemaCore LLC Electronic Equipment/InstrumentsElectronic Technology HemaCore LLC operates as a biotech company that develops medical devices and methods for hematology. Its product Thrombodynamics is a new global assay for monitoring and prognosis of blood coagulation disorders: bleeding and thrombosis, precursors of heart attacks and strokes. The company was founded in April 2010 by Igor Pivovarov and is headquartered in Moscow, Russia. | Directeur/Membre du Conseil | - |
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Directeur/Membre du Conseil | 01/01/2011 |
Rusnano Management Co. LLC
 Rusnano Management Co. LLC Investment ManagersFinance Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia. | Private Equity Investor | 11/02/2014 |
Anciens postes connus de Leysan Shaydullina
| Sociétés | Poste | Fin |
|---|---|---|
Rusnano OJSC
 Rusnano OJSC Miscellaneous Commercial ServicesCommercial Services Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation. | Corporate Officer/Principal | 01/01/2009 |
| Idea Innovative Technopark CJSC | Directeur en chef des Investissements | 01/01/2008 |
| CARTESIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Leysan Shaydullina
| Kazan State Medical University | Doctorate Degree |
| The Russian Presidential Academy of National Economy & Public | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
HemaCore LLC
HemaCore LLC Electronic Equipment/InstrumentsElectronic Technology HemaCore LLC operates as a biotech company that develops medical devices and methods for hematology. Its product Thrombodynamics is a new global assay for monitoring and prognosis of blood coagulation disorders: bleeding and thrombosis, precursors of heart attacks and strokes. The company was founded in April 2010 by Igor Pivovarov and is headquartered in Moscow, Russia. | Electronic Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
| Idea Innovative Technopark CJSC | |
Rusnano Management Co. LLC
Rusnano Management Co. LLC Investment ManagersFinance Rusnano Management Co. LLC (Rusnano Management) is a private equity and venture capital subsidiary of the State-owned Rusnano OJSC. The firm was founded in 2013 and is headquartered in Moscow, Russia. | Finance |
Rusnano OJSC
Rusnano OJSC Miscellaneous Commercial ServicesCommercial Services Rusnano OJSC operates as an investment company focusing on nanotechnology. Its activities include building nanotechnology infrastructure, which includes the nanotechnology centers of excellence, business incubators and early stage investment funds; It also provides scientific and educational programs. The company was founded on September 19, 2007 and is headquartered in Moscow, Russian Federation. | Commercial Services |